2018
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)., Lori J Wirth, Makoto Tahara, Bruce Robinson, Sanjeev Francis, Marcia S Brose, Mouhammed Amir Habra, Kate Newbold, Naomi Kiyota, Corina E Dutcus, Elton Mathias, Matthew Guo, Steven I Sherman, and Martin Schlumberger (Article)
Race as a Predictor of Palliative Care Referral Time, Hospice Utilization, and Hospital Length of Stay: A Retrospective Noncomparative Analysis., Brooke Worster, Declan Kennedy Bell, Vibin Roy, Amy Cunningham, Marianna LaNoue, and Susan Parks (Article)
A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer., Zhong Ye, Chun Wang, Limin Guo, Juan P Palazzo, Zhixing Han, Yinzhi Lai, Jing Jiang, James A Posey, Atrayee Basu Mallick, Bingshan Li, Li Jiang, and Hushan Yang (Article)
ATM/RB1 mutations predict shorter overall survival in urothelial cancer, Ming Yin, Petros Grivas, Hamid Emamekhoo, Prateek Mendiratta, Siraj Ali, JoAnn Hsu, Monali Vasekar, Joseph J Drabick, Sumanta Pal, and Monika Joshi (Article)
Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results., Matthew Ziegler, Daniel Landsburg, David Pegues, Kevin Alby, Cheryl Gilmar, Kristen Bink, Theresa Gorman, Amy Moore, Brittaney Bonhomme, Jacqueline Omorogbe, Dana Tango, Pam Tolomeo, and Jennifer H Han (Article)
2017
Co-existence of Antiphospholipid syndrome and Heparin-induced Thrombocytopenia in a patient with Recurrent Venous Thromboembolism., Samuel Adediran MD and Nicole M. Agostino DO (Article)
Primary Pulmonary Carcinoid Tumors: A Single Institution Retrospective Review: Topic: Medical Oncology, Samuel Adediran MD, Eliot L. Friedman MD, and Ranjit R. Nair MD (Poster)
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases., Staci D Arnold; Ruta Brazauskas; Naya He; Yimei Li; Richard Aplenc; Zhezhen Jin; Matt Hall; Yoshiko Atsuta; Jignesh Dalal; Theresa Hahn; Nandita Khera; Carmem Bonfim; Navneet S Majhail; Miguel Angel Diaz; Cesar O Freytes; William A Wood; Bipin N Savani; Rammurti T Kamble; Susan Parsons; Ibrahim Ahmed; Keith Sullivan; Sara Beattie; Christopher Dandoy; Reinhold Munker; Susana Marino; Menachem Bitan; Hisham Abdel-Azim; Mahmoud Aljurf; Richard F Olsson; Sarita Joshi; Dave Buchbinder; Michael J Eckrich; Shahrukh Hashmi; Hillard Lazarus; David I Marks; Amir Steinberg; Ayman Saad; Usama Gergis MD, MBA; Lakshmanan Krishnamurti; Allistair Abraham; Hemalatha G Rangarajan; Mark Walters; Joseph Lipscomb; Wael Saber; and Prakash Satwani (Article)
let-7 miRNA controls CED-7 homotypic adhesion and EFF-1-mediated axonal self-fusion to restore touch sensation following injury, Atrayee Basu, Shirshendu Dey, Dharmendra Puri, Nilanjana Das Saha, Vidur Sabharwal, Pankajam Thyagarajan, Prerna Srivastava, Sandhya Padmanabhan Koushika, and Anindya Ghosh-Roy (Article)
Risk of suicide in persons with gastrointestinal cancer: A population-based study, A Basu Mallick (Article)
Suicide risk in persons with colorectal cancer: A population-based study., A Basu Mallick (Article)
Conditioning neoadjuvant therapies for improved immunotherapy of cancer., Zachary Benson, Saeed H Manjili, Mehran Habibi, Georgi Guruli, Amir Toor MD, Kyle K Payne, and Masoud H Manjili (Article)
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection., Patrick M Boland, Joshua E Meyer, Adam C Berger, Steven J Cohen, Tzahi Neuman, Harry S Cooper, Anthony J Olszanski, Monica Davey, Jonathan D Cheng, Abraham Lebenthal, Barbara A Burtness, Walter J Scott, and Igor A Astsaturov (Article)
The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers, M Brose (Article)
Timing of multikinase inhibitor initiation in differentiated thyroid cancer., Marcia S Brose, Johannes Smit, Chia-Chi Lin, Fabian Pitoia, Marc Fellous, Yoriko DeSanctis, Martin Schlumberger, Masayuki Tori, and Iwao Sugitani (Article)
Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial., Marcia S Brose, Francis P Worden, Kate L Newbold, Matthew Guo, and Arti Hurria (Article)
Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions, M S. Brose (Article)
Impact of duration of dose interruption on the efficacy of lenvatinib (LEN) in a phase 3 sudy in patients (pts) with radioiodine refractory differentiated thyroid cancer (RR-DTC), M S. Brose (Article)
Prognostic impact of RNA expression profile (EP) in the phase III DECISION trial for patients with advanced radioactive-iodine refractory differentiated thyroid cancer (DTC), M S. Brose (Article)
Disseminated, Jason Chen, Jonathan Pan, Joanne Filicko-O'Hara, Margaret Kasner, and Phyllis Flomenberg (Article)
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies., Hannah K Choe; Usama Gergis MD, MBA; Sebastian A Mayer; Himanshu Nagar; Adrienne A Phillips; Tsiporah B Shore; Michael J Smith; and Koen van Besien (Article)
A phase 1b/2 study of INCB039110 + nab-paclitaxel (N) and gemcitabine (G) in patients (pts) with advanced solid tumors and pancreatic cancer (PC), S J. Cohen (Article)
Physical activity intervention for patients with advanced pancreatic cancer., S J. Cohen (Article)
RNA profiling of neuroendocrine tumors (NETs) to define new targets and mechanisms of progression, S J. Cohen (Article)
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer., Efrat Dotan, Steven J Cohen, Alexander N Starodub, Christopher H Lieu, Wells A Messersmith, Pamela S Simpson, Michael J Guarino, John L Marshall, Richard M Goldberg, J Randolph Hecht, William A Wegener, Robert M Sharkey, Serengulam V Govindan, David M Goldenberg, and Jordan D Berlin (Article)
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation., Areej El-Jawahri; Yi-Bin Chen; Ruta Brazauskas; Naya He; Stephanie J Lee; Jennifer M Knight; Navneet Majhail; David Buchbinder; Raquel M Schears; Baldeep M Wirk; William A Wood; Ibrahim Ahmed; Mahmoud Aljurf; Jeff Szer; Sara M Beattie; Minoo Battiwalla; Christopher Dandoy; Miguel-Angel Diaz; Anita D'Souza; Cesar O Freytes; James Gajewski; Usama Gergis MD, MBA; Shahrukh K Hashmi; Ann Jakubowski; Rammurti T Kamble; Tamila Kindwall-Keller; Hilard M Lazarus; Adriana K Malone; David I Marks; Kenneth Meehan; Bipin N Savani; Richard F Olsson; David Rizzieri; Amir Steinberg; Dawn Speckhart; David Szwajcer; Helene Schoemans; Sachiko Seo; Celalettin Ustun; Yoshiko Atsuta; Jignesh Dalal; Carmem Sales-Bonfim; Nandita Khera; Theresa Hahn; and Wael Saber (Article)
Analysis of the Impact of Donor Characteristics on Outcomes after 2-Step Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT), Joanne Filicko-O'Hara (Article)
A Phase II Study of Azacitidine and Sirolimus for the Treatment of Acute Myeloid Leukemia (AML) Refractory to or Not Eligible for Intensive Chemotherapy or High Risk Myelodysplastic Syndrome (MDS), Joanne Filicko-O'Hara (Article)
A Phase II Trial of Sirolimus with Standard Induction Chemotherapy in Patients with De Novo Acute Myeloid Leukemia, Joanne Filicko-O'Hara (Article)
Brentuximab Vedotin with R-CHP Chemotherapy As Frontline Treatment for Patients with CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, and Grey Zone Lymphomas: Results of a Phase I/II Multisite Trial, Joanne Filicko-O'Hara (Article)
Differences in Allogeneic Product T-Cell Subsets According to Donor Age: Associations with Immune Reconstitution and Acute Graft Versus Host Disease (aGVHD) in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT), Joanne Filicko-O'Hara (Article)
The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT), Joanne Filicko-O'Hara (Article)
BA-010 - Prognostic utility of immune markers and validation of Immunoscore in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance), A S. Frank, Q Shi, F Hermitte, E Heying, B B. Al, S Gill, M G. Richard, M Kahlenberg, Suresh G. Nair MD, A Shields, D Sargent, J Galon, and R A. Steven (Article)
Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome., P R Geethakumari, B Leiby, R Nair, S O Alpdogan, M Carabasi, J Filicko-O'Hara, S Gaballa, M Kasner, T Klumpp, U Martinez-Outschoorn, N Palmisiano, J L Wagner, P Porcu, N Flomenberg, and D Grosso (Article)
293 - A Pilot Study of a Sequential Regimen of Intensive Chemotherapy (Bendamustine-Bridge) Followed by Autologous or Allogeneic Transplantation for Refractory Lymphomas, Usama Gergis MD, MBA (Article)
359 - Bortezomib and Immune Globulin Desensitization for Donor-Specific HLA Antibodies in Haplo-Cord Stem Cell Transplantation, Usama Gergis MD, MBA (Article)
Perspectives of HER2-targeting in gastric and esophageal cancer., James N Gerson, Sam Skariah MD, Crystal S Denlinger, and Igor Astsaturov (Article)
Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma., Mahasweta Gooptu, Diana Whitaker-Menezes, John Sprandio, Marina Domingo-Vidal, Zhao Lin, Guldeep Uppal, Jerald Gong, Roberto S Fratamico MD, Benjamin Leiby, Alina Dulau-Florea, Jaime Caro, and Ubaldo Martinez-Outschoorn (Article)
The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers., Carolyn Grande, Constance Visovsky, and Marcia S Brose (Article)
Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization., D Grosso, E Johnson, B Colombe, O Alpdogan, M Carabasi, J Filicko-O'Hara, S Gaballa, M Kasner, T Klumpp, U Martinez-Outschoorn, J L Wagner, M Weiss, Z Wang, and N Flomenberg (Article)
Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity., Charles E Hall, Vishal N Koparde, Maximilian Jameson-Lee, Abdelrhman G Elnasseh, Allison F Scalora, David J Kobulnicky, Myrna G Serrano, Catherine H Roberts, Gregory A Buck, Michael C Neale, Daniel E Nixon, and Amir Toor MD (Article)
MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer., Jennifer M Johnson, Paolo Cotzia, Roberto S Fratamico MD, Lekha Mikkilineni, Jason Chen, Daniele Colombo, Mehri Mollaee, Diana Whitaker-Menezes, Marina Domingo-Vidal, Zhao Lin, Tingting Zhan, Madalina Tuluc, Juan Palazzo, Ruth C Birbe, and Ubaldo E Martinez-Outschoorn (Article)
Low-dose splenic irradiation prior to hematopoietic cell transplantation in hypersplenic patients with myelofibrosis., Noah S Kalman, Nitai D Mukhopadhyay, Catherine H Roberts, Harold M Chung, William B Clark, John M McCarty, Amir Toor MD, and Shiyu Song (Article)
ABO Blood Type and the Risk of Cardovascular Events: An Analysis of Framingham Data and Meta-Analysis, M Kasner (Article)
Primary aleukemic myeloid leukemia cutis remission following radiotherapy, M Kasner (Article)
Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer., Andrew S Kennedy, David Ball, Steven J Cohen, Michael Cohn, Douglas M Coldwell, Alain Drooz, Edward Ehrenwald, Samir Kanani, Fred M Moeslein, Charles W Nutting, Samuel G Putnam, Steven C Rose, Michael Savin, Sabine Schirm, Navesh K Sharma, and Eric Wang (Article)
Improved survival after acute graft-, Hanna J Khoury; Tao Wang; Michael T Hemmer; Daniel Couriel; Amin Alousi; Corey Cutler; Mahmoud Aljurf; Joseph H Antin; Mouhab Ayas; Minoo Battiwalla; Jean-Yves Cahn; Mitchell Cairo; Yi-Bin Chen; Robert Peter Gale; Shahrukh Hashmi; Robert J Hayashi; Madan Jagasia; Mark Juckett; Rammurti T Kamble; Mohamed Kharfan-Dabaja; Mark Litzow; Navneet Majhail; Alan Miller; Taiga Nishihori; Muna Qayed; Helene Schoemans; Harry C Schouten; Gerard Socie; Jan Storek; Leo Verdonck; Ravi Vij; William A Wood; Lolie Yu; Rodrigo Martino; Matthew Carabasi; Christopher Dandoy; Usama Gergis MD, MBA; Peiman Hematti; Melham Solh; Kareem Jamani; Leslie Lehmann; Bipin Savani; Kirk R Schultz; Baldeep M Wirk; Stephen Spellman; Mukta Arora; and Joseph Pidala (Article)
Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation., Vishal Koparde, Badar Abdul Razzaq, Tara Suntum, Roy Sabo, Allison Scalora, Myrna Serrano, Max Jameson-Lee, Charles Hall, David Kobulnicky, Nihar Sheth, Juliana Feltz, Daniel Contaifer, Dayanjan Wijesinghe, Jason Reed, Catherine Roberts, Rehan Qayyum, Gregory Buck, Michael Neale, and Amir Toor MD (Article)
An open-label phase 3b/4 safety trial of flat-dose nivolumab plus ipilimumab in patients with advanced non-small cell lung cancer (NSCLC), Bradley Lash (Article)
A open-label phase 3b/4 safety trial of flat-dose nivolumab in combination with ipilimumab in patients with advanced non-small cell lung cancer (NSCLC), Bradley Lash MD (Article)
Your Guide to Immunotherapy, Lehigh Valley Health Network and ACCC Association of Community Cancer Centers (Article)
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia., Hien Duong Liu; Kwang Woo Ahn; Zhen-Huan Hu; Mehdi Hamadani; Taiga Nishihori; Baldeep Wirk; Amer Beitinjaneh; David Rizzieri; Michael R Grunwald; Mitchell Sabloff; Richard F Olsson; Ashish Bajel; Christopher Bredeson; Andrew Daly; Yoshihiro Inamoto; Navneet Majhail; Ayman Saad; Vikas Gupta; Aaron Gerds; Adriana Malone; Martin Tallman; Ran Reshef; David I Marks; Edward Copelan; Usama Gergis MD, MBA; Mary Lynn Savoie; Celalettin Ustun; Mark R Litzow; Jean-Yves Cahn; Tamila Kindwall-Keller; Gorgun Akpek; Bipin N Savani; Mahmoud Aljurf; Jacob M Rowe; Peter H Wiernik; Jack W Hsu; Jorge Cortes; Matt Kalaycio; Richard Maziarz; Ronald Sobecks; Uday Popat; Edwin Alyea; and Wael Saber (Article)
Review of Cases of Carcinoid Tumors and Neuroendocrine Carcinoma Diagnosed at Lehigh Valley Health Network From 2011-2015, Katlyn Mayer and Savitri Skandan MD (Poster)
DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle., Andrey Mikheikin, Anita Olsen, Kevin Leslie, Freddie Russell-Pavier, Andrew Yacoot, Loren Picco, Oliver Payton, Amir Toor MD, Alden Chesney, James K Gimzewski, Bud Mishra, and Jason Reed (Article)
Association of Micropapillary Architecture and High Tumor Budding with Prognosis in Patients with Stage III Colon Cancer from a FOLFOX-Based Adjuvant Chemotherapy Trial: NCCTG N0147 (Alliance), Suresh G. Nair MD (Article)
Genetic correlates of therapeutic toxicities of stage III colon carcinoma patients treated with adjuvant FOLFOX+/-cetuximab (NCCTG N0147, Alliance)., Suresh G. Nair MD (Article)
Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with, Kazim H Narsinh, Mark Van Buskirk, Andrew S Kennedy, Mohammed Suhail, Naif Alsaikhan, Carl K Hoh, Kenneth Thurston, Jeet Minocha, David S Ball, Steven J Cohen, Michael Cohn, Douglas M Coldwell, Alain Drooz, Eduardo Ehrenwald, Samir Kanani, Charles W Nutting, Fred M Moeslein, Michael A Savin, Sabine Schirm, Samuel G Putnam, Navesh K Sharma, Eric A Wang, and Steven C Rose (Article)
Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation., Jonathan Pan, Jason Chen, Joanne Filicko, Dolores Grosso, Michelle Nagurney, Onder Alpdogan, and Neal Flomenberg (Article)
A comparison of genomic assays in determining risk of late recurrence and benefit of extended endocrine therapy (EET)., K Rague, L M. Rico, Eddy Yu MD, B Carter, and T G. Frazier (Article)
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma., M Schlumberger, R Elisei, S Müller, P Schöffski, M Brose, M Shah, L Licitra, J Krajewska, M C Kreissl, B Niederle, E E W Cohen, L Wirth, H Ali, D O Clary, Y Yaron, M Mangeshkar, D Ball, B Nelkin, and S Sherman (Article)
Metastatic adenocarcinoma of the pancreas presents as metastases to the axillary/supraclavicular region as the first sign of the disease., Blake A Stewart, Abdul Adjei, Xiaohong Zhang, and Jacqueline Oxenberg DO (Article)
Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model., Jay E Sulek, Samuel P Robinson, Albert A Petrossian, Shaoqing Zhou, Ekaterine Goliadze, Masoud H Manjili, Amir Toor MD, and Georgi Guruli (Article)
P226 FRACTION-RCC: a randomized, open-label, adaptive, phase 2 study of nivolumab in combination with other immuno-oncology agents in patients with advanced RCC., Corina C. Taitt, Robert J. Motzer, Toni K. Choueiri, Bernard J. Escudier, Timothy Kuzel, Michael A. Carducci MD, Suresh G. Nair MD, Scott S. Tykodi, Sarah Tannenbaum-Dvir, Megan Wind-Rotolo, Katy L. Simonsen, and Paula M. Fracasso (Article)
198 - Whole Exome Sequencing and in silico Determination of the Magnitude of Alloreactive Antigen Presentation on HLA DRB1 in Allogeneic Stem Cell Transplant Recipients, Amir Toor MD (Article)
209 - Dynamical System Interactions between T Cells and Monocytes Shape Alloreactivity Following Stem Cell Transplantation, Amir Toor MD (Article)
299 - Low Plasma Vitamin C Levels in Patients Undergoing Stem Cell Transplantation, Amir Toor MD (Article)
447 - Single-Cell Mass Profiling of Reconstituting Donor T Cells Following Stem Cell Transplantation to Predict Alloreactivity, Amir Toor MD (Article)
93 - Cytomegalovirus Antigenic Mimicry of Human Alloreactive Peptides: Exploring Cross-Reactivity As a Potential Trigger for Graft Versus Host Disease, Amir Toor MD (Article)
94 - Whole Exome Sequencing to Determine the Likelihood of Graft Versus Host Disease in Stem Cell Transplant Donor-Recipient Pairs, Amir Toor MD (Article)
Novel concepts for initiating multitargeted kinase inhibitors in radioactive iodine refractory differentiated thyroid cancer., R Michael Tuttle, Marcia S Brose, Enrique Grande, Sun Wook Kim, Makoto Tahara, and Mona M Sabra (Article)
Haplo-cord transplant: HLA-matching determines graft dominance., Koen van Besien; Nebu Koshy; Usama Gergis MD, MBA; Sebastian Mayer; Melissa Cushing; Hannah Rennert; Ronit Reich-Slotky; Tomer Mark; Roger Pearse; Adriana Rossi; Adrienne Phillips; Liljana Vasovic; Rosanna Ferrante; Yen-Michael Hsu; and Tsiporah Shore (Article)
Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis., Q Wei, Z Ye, X Zhong, L Li, C Wang, R E Myers, J P Palazzo, D Fortuna, A Yan, S A Waldman, X Chen, J A Posey, A Basu-Mallick, B H Jiang, L Hou, J Shu, Y Sun, J Xing, B Li, and H Yang (Article)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial., Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M O'Rourke, Mark Wong, Mark G Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D Turner, Michael J Yellin, Tibor Keler, Thomas A Davis, Roger Stupp, John H Sampson, and Suresh G. Nair MD (Article)
Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma., Zachary Wolfe MD and Bradley Lash MD (Article)
Telemedicine and Palliative Care: an Increasing Role in Supportive Oncology., Brooke Worster and Kristine Swartz (Article)
2016
Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy., Sherif R Z Abdel-Misih, Lai Wei, Al B Benson, Steven Cohen, Lily Lai, John Skibber, Neal Wilkinson, Martin Weiser, Deborah Schrag, and Tanios Bekaii-Saab (Article)
Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor-Recipient Pairs., Badar Abdul Razzaq, Allison Scalora, Vishal N Koparde, Jeremy Meier, Musa Mahmood, Salman Salman, Max Jameson-Lee, Myrna G Serrano, Nihar Sheth, Mark Voelkner, David J Kobulnicky, Catherine H Roberts, Andrea Ferreira-Gonzalez, Masoud H Manjili, Gregory A Buck, Michael C Neale, and Amir Toor MD (Article)
An Extremely Indolent T-cell Leukemia: An 18-year Follow-Up., Samuel Adediran MD, Dennis B. Cornfield MD, Adam Bagg, and Nicole M. Agostino DO (Article)
Biomarkers of prognosis in patients with differentiated thyroid cancer: Results from the DECISION trial, M Brose (Article)
Pembrolizumab for advanced papillary or follicular thyroid cancer: preliminary results from the phase 1b KEYNOTE-028 study., M Brose (Article)
Sequencing of Tyrosine Kinase Inhibitors in Progressive Differentiated Thyroid Cancer., Marcia S Brose (Article)
Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial., Marcia S Brose, Maria E Cabanillas, Ezra E W Cohen, Lori J Wirth, Todd Riehl, Huibin Yue, Steven I Sherman, and Eric J Sherman (Article)
Vemurafenib for BRAF, Marcia S Brose and Nathan Singh (Article)
Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions, M S. Brose (Article)
Tumor growth rate analysis of progression-free survival (PFS) and overall survival (OS) for thyroid cancer patients receiving placebo or sorafenib in the phase 3 DECISION trial, M S. Brose (Article)
Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation., Frank Cirrone; Cindy Ippoliti; Hanhan Wang; Xi Kathy Zhou; Usama Gergis MD, MBA; Sebastian Mayer; Tsiporah Shore; and Koen van Besien (Article)
Changing patterns of metastatic pancreatic cancer (mPC) care in the combination therapy era: A geriatric perspective., S J. Cohen (Article)
Chemotherapy (Ctx) use and adoption of new agents in older versus younger patients (pts) with metastatic colorectal cancer (mCRC, S J. Cohen (Article)
Chemotherapy (Ctx) use and adoption of new agents in older versus younger patients (pts) with metastatic colorectal cancer (mCRC), S J. Cohen (Article)
Nutritional status and outcomes of older versus younger patients (pts) with metastatic pancreatic cancer (mPC), S J. Cohen (Article)
Patients with rectal cancer after treatment of prostate cancer: A single institutition experience., S J. Cohen (Article)
RAS family mutation patterns in a large cohort of CRCs, S J. Cohen (Article)
Safety and efficacy of combination of temozolomide and pazopanib in patients with advanced pancreatic neuroendocrine tumors (PNET), S J. Cohen (Article)
The association between sarcopenia and treatment outcomes in patients with pancreatic cancer undergoing chemoradiation, S J. Cohen (Article)
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study., Steven J Cohen, Bert H O'Neil, Jordan Berlin, Patricia Ames, Marti McKinley, Julie Horan, Patricia M Catalano, Angela Davies, Colin D Weekes, and Lawrence Leichman (Article)
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma., Efrat Dotan, R Katherine Alpaugh, Karen Ruth, Benjamin P Negin, Crystal S Denlinger, Michael J Hall, Igor Astsaturov, Cecilia McAleer, Patricia Fittipaldi, Catherine Thrash-Bingham, Neal J Meropol, and Steven J Cohen (Article)
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers., Peter C Enzinger, Barbara Ann Burtness, Donna Niedzwiecki, Xing Ye, Kathe Douglas, David H Ilson, Victoria Meucci Villaflor, Steven J Cohen, Robert J Mayer, Alan Venook, Al Bowen Benson, and Richard M Goldberg (Article)